Small molecule drug development for rare genodermatoses – evaluation of the current status in epidermolysis bullosa

BACKGROUND: Hereditary epidermolysis bullosa (EB) comprises a heterogeneous group of rare genodermatoses, which are caused by mutations in genes involved in the maintenance of the structural and functional integrity of dermo-epidermal adhesion in various stratified epithelia. In severe variants, gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wally, Verena, Reisenberger, Manuela, Kitzmüller, Sophie, Laimer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574495/
https://www.ncbi.nlm.nih.gov/pubmed/33076941
http://dx.doi.org/10.1186/s13023-020-01467-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574495/
https://www.ncbi.nlm.nih.gov/pubmed/33076941
http://dx.doi.org/10.1186/s13023-020-01467-9

Ejemplares similares